IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Vallon Pharmaceuticals Inc

CUSIP: 92023M101 | 34 institutional holders

Quarters

Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022
CompareDetailedHistoricalFundsOptions13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q1 2023

Two Sigma Securities, LLC22,708
0.0% of portfolio›$8.2K
Geode Capital Management, LLC21,569
0.0% of portfolio›$7.8K
State Street Corp18,921
0.0% of portfolio›$6.8K
Susquehanna International Group, LLP15,109
0.0% of portfolio›$5.5K
Tower Research Capital LLC (TRC)11,907
0.0% of portfolio›$4
Citadel Advisors LLC11,095
0.0% of portfolio›$4.0K
UBS Group AG2,919
0.0% of portfolio›$1.1K
Archer Investment Corp100
0.0% of portfolio›$36
Wells Fargo & Company58
0.0% of portfolio›$21
Proequities, Inc.0
0.0% of portfolio›$0
StyleTurnoverLocationFiled
Two Sigma Securities, LLC
22,708$8.2K0.0%ValueVery HighNew York, NY2023-05-15
Geode Capital Management, LLC
21,569$7.8K0.0%IndexVery LowBoston, MA2023-05-15
State Street Corp
18,921$6.8K0.0%IndexVery LowBoston, MA2023-05-15
Susquehanna International Group, LLP
15,109$5.5K0.0%GrowthHighBala Cynwyd, PA2023-05-16
Tower Research Capital LLC (TRC)
11,907$40.0%GARPVery HighNew York, NY2023-05-09
Citadel Advisors LLC
11,095$4.0K0.0%CoreVery HighMiami, FL2023-05-15
UBS Group AG
2,919$1.1K0.0%CoreMediumZurich, Switzerland2023-05-12
Archer Investment Corp
100$360.0%CoreMediumCarmel, IN2023-05-09
Wells Fargo & Company
58$210.0%CoreLowSan Francisco, CA2023-05-12
Proequities, Inc.
0$00.0%GrowthVery LowBirmingham, AL2023-05-15